Meanings
nounbrepocitinib (uncountable)
- uncountablemedicineAn experimental medication belonging to the class of Janus kinase inhibitors.
PF-06826647 is a TYK2-selective jakinib (68) currently in trials for the treatment of psoriasis, UC, and hidradenitis suppurativa; brepocitinib is a TYK2/JAK1 inhibitor that was assessed in a phase II trial of psoriasis where clinical responses were seen with all doses (69).
2021 December, Christine Liu, Jacqueline Kieltyka, Roy Fleischmann, Massimo Gadina, John J. O’Shea, “A Decade of JAK Inhibitors: What Have We Learned and What May Be the Future?”, in Arthritis & Rheumatology, volume 73, number 12, →DOI, page 2172
Cite this entry
APA
brepocitinib. (n.d.). In WatkinsX Dictionary. Retrieved November 4, 2026, from https://dictionary.watkinsx.com/word/brepocitinib
MLA
“brepocitinib.” WatkinsX Dictionary, https://dictionary.watkinsx.com/word/brepocitinib. Accessed November 4, 2026.
Chicago
WatkinsX Dictionary, s.v. “brepocitinib,” accessed November 4, 2026, https://dictionary.watkinsx.com/word/brepocitinib.
Source: brepocitinib on Wiktionary, CC BY-SA 4.0.